BDNF (P23560) variants and mutations
BDNF (also known as P23560) is a human protein-coding gene encoding a neurotrophic factor BDNF precursor form protein. It supports neuronal survival, synaptic maturation, plasticity, and activity-dependent remodeling by activating TrkB signaling. Altered BDNF signaling has broad effects on cognition, mood, metabolism, and neurodevelopment, although most common human variation has modest and context-dependent effects. This analysis covers 562 BDNF variants and mutations. Of these, 94% have computational variant effect predictions. Disease context includes Abnormality of the skeletal system, obesity disorder, and smoking initiation. Example BDNF variants include T2I, T2N, and T2S.
Variant analysis overview
- Gene: BDNF
- Protein: P23560
- UniProt accession: P23560
- Organism: Homo sapiens
- Variants analyzed: 562
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 255 unspecified-consequence records; 166 missense variants; 118 synonymous variants; 5 in-frame deletions; 1 in-frame insertions; 1 splice-region variants; 10 frameshift variants; 6 stop-gained variants
- Prediction scores: 529 variants have prediction scores (94% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Abnormality of the skeletal system, obesity disorder, smoking initiation, type 2 diabetes mellitus, diverticular disease, metabolic syndrome, heart failure, gout, Snoring, cancer, mathematical ability, overnutrition.
Protein structure and variant hotspots
- Protein features: 1 post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable BDNF variants
Examples include T2I, T2N, T2S, I3N, I3M, L4I, L4V, F5L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- T2I (p.Thr2Ile), rs8192466, ClinGen CA258058, cosmic curated COSV10512, ClinVar RCV000019266, REVEL 0.41, CADD 24.30, Conflicting interpretations, not specified; not provided; Obesity
- T2N (p.Thr2Asn), rs8192466, ClinGen CA5929149, ClinVar RCV003404640, ClinVar RCV006616884, REVEL 0.26, CADD 25.40, Uncertain significance, not provided
- T2S (p.Thr2Ser), gnomAD 11-27658560-G-C, REVEL 0.38, MetaLR 0.26
- I3N (p.Ile3Asn), cosmic curated COSV10440, MetaLR 0.29, MetaSVM -0.49
- I3M (p.Ile3Met), gnomAD 11-27658556-G-C, REVEL 0.38, MetaLR 0.31
- L4I (p.Leu4Ile), cosmic curated COSV10812
- L4V (p.Leu4Val), gnomAD rs1431475678, REVEL 0.27, CADD 23.30
- F5L (p.Phe5Leu), gnomAD rs1253363411, REVEL 0.31, CADD 22.60
- F5F (p.Phe5Phe), rs1415125856, gnomAD 11-27658550-G-A, CADD 11.50
- L6I (p.Leu6Ile), gnomAD rs1184013173, REVEL 0.24, CADD 23.50
- L6R (p.Leu6Arg), cosmic curated COSV59233
- L6L (p.Leu6Leu), rs1564941203, gnomAD 11-27658547-A-G, CADD 11.60
- L6P (p.Leu6Pro), rs369607397, gnomAD 11-27674238-A-G, CADD 13.30, SIFT 0.00
- L6V (p.Leu6Val), rs1486010936, gnomAD 11-27674239-G-C, CADD 16.40, SIFT 0.00
- L6F (p.Leu6Phe), gnomAD 11-27674239-G-A, CADD 17.80, SIFT 0.00
- L6N (p.Leu6Asn), rs747002774, gnomAD 11-27674240-G-GAT, CADD 24.80
- L6H (p.Leu6His), gnomAD 11-27674262-A-T, CADD 18.70, SIFT 0.00
- T7A (p.Thr7Ala), rs779925777, ExAC rs779925777, gnomAD rs779925777, AlphaMissense 0.31, MetaLR 0.13, Variant assessed as somatic; moderate impact.
- T7I (p.Thr7Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- T7N (p.Thr7Asn), NCI-TCGA TCGA novel, MetaLR 0.17, MetaSVM -0.93, Variant assessed as somatic; moderate impact.
- T7T (p.Thr7Thr), rs748392649, gnomAD 11-27674249-T-C, CADD 4.91
- T7R (p.Thr7Arg), rs1855795619, gnomAD 11-27674250-G-C, CADD 0.60, SIFT 0.00
- T7P (p.Thr7Pro), gnomAD 11-27674251-T-G, CADD 1.10, SIFT 0.00
- M8I (p.Met8Ile), NCI-TCGA Cosmic COSV5923, cosmic curated COSV59235, MetaLR 0.17, MetaSVM -0.89, Variant assessed as somatic; moderate impact.
- V9I (p.Val9Ile), NCI-TCGA Cosmic COSV5923, cosmic curated COSV59238, Variant assessed as somatic; moderate impact.
- V9G (p.Val9Gly), rs1163567412, gnomAD 11-27658566-A-C, MetaLR 0.47, MetaSVM -0.00
- V9A (p.Val9Ala), gnomAD 11-27658566-A-G, MetaLR 0.42, MetaSVM -0.12
- V9V (p.Val9Val), gnomAD 11-27658574-C-T, CADD 11.50
- V9M (p.Val9Met), gnomAD 11-27658576-C-T, MetaLR 0.44, MetaSVM -0.15
- V9D (p.Val9Asp), gnomAD 11-27674235-A-T, CADD 9.53, SIFT 0.00
- V9F (p.Val9Phe), gnomAD 11-27674236-C-A, CADD 1.92, SIFT 0.00
- V9L (p.Val9Leu), rs2133915767, gnomAD 11-27674236-C-G, CADD 0.34, SIFT 0.31
- I10F (p.Ile10Phe), gnomAD 11-27658537-T-A, REVEL 0.31, MetaLR 0.16
- I10I (p.Ile10Ile), gnomAD 11-27674240-G-T, CADD 8.17
- I10M (p.Ile10Met), gnomAD 11-27674240-G-C, CADD 22.00, SIFT 0.00
- I10N (p.Ile10Asn), rs1259467589, gnomAD 11-27674241-A-T, CADD 23.60, SIFT 0.00
- I10T (p.Ile10Thr), rs1259467589, gnomAD 11-27674241-A-G, CADD 21.90, SIFT 0.00
- I10V (p.Ile10Val), gnomAD 11-27674242-T-C, CADD 22.20, SIFT 0.00
- S11L (p.Ser11Leu), rs866172975, NCI-TCGA Cosmic COSV5923, cosmic curated COSV59236, Ensembl rs866172975, AlphaMissense 0.58, MetaLR 0.24, Variant assessed as somatic; moderate impact.
- S11P (p.Ser11Pro), gnomAD 11-27658534-A-G, REVEL 0.36, MetaLR 0.22
- S11S (p.Ser11Ser), gnomAD 11-27674267-A-G, CADD 7.53
- S11F (p.Ser11Phe), rs1287429853, gnomAD 11-27674268-CTG-C, CADD 24.40
- S11N (p.Ser11Asn), gnomAD 11-27674268-C-T, CADD 20.60, SIFT 0.00
- S11G (p.Ser11Gly), gnomAD 11-27674269-T-C, CADD 17.50, SIFT 0.00
- Y12C (p.Tyr12Cys), NCI-TCGA Cosmic COSV5923, cosmic curated COSV59238, Ensembl rs2133785109, MetaLR 0.23, MetaSVM -0.66, Variant assessed as somatic; moderate impact.
- Y12H (p.Tyr12His), gnomAD 11-27658531-A-G, REVEL 0.45, MetaLR 0.23
- F13C (p.Phe13Cys), Ensembl rs1564941169, MetaLR 0.23, MetaSVM -0.69
- F13F (p.Phe13Phe), rs758200229, gnomAD 11-27658526-A-G, CADD 11.20
- F13L (p.Phe13Leu), rs1855779140, gnomAD 11-27674179-CA-C, CADD 22.00
- F13S (p.Phe13Ser), gnomAD 11-27674181-A-G, CADD 17.30, SIFT 0.00
- G14V (p.Gly14Val), gnomAD 11-27674277-C-A, CADD 22.90, SIFT 0.00
- G14E (p.Gly14Glu), gnomAD 11-27674277-C-T, CADD 19.90, SIFT 0.00
- G14* (p.Gly14Ter), gnomAD 11-27674278-C-A, CADD 33.00
- G14R (p.Gly14Arg), gnomAD 11-27674278-C-T, CADD 22.10, SIFT 0.00
- C15R (p.Cys15Arg), gnomAD 11-27658522-A-G, REVEL 0.41, MetaLR 0.27
- C15C (p.Cys15Cys), gnomAD 11-27674123-A-G, CADD 7.55
- C15Y (p.Cys15Tyr), rs1366381543, gnomAD 11-27674145-C-T, CADD 8.60, SIFT 0.15
- C15S (p.Cys15Ser), gnomAD 11-27674146-A-T, CADD 22.20, SIFT 0.01
- C15F (p.Cys15Phe), rs539177035, gnomAD 11-27674184-CAT-C, CADD 23.00
- C15G (p.Cys15Gly), gnomAD 11-27674185-A-C, CADD 14.90, SIFT 0.00
- C15W (p.Cys15Trp), rs1564961314, gnomAD 11-27674252-G-C, CADD 12.40, SIFT 0.14
- C15* (p.Cys15Ter), gnomAD 11-27674252-G-T, CADD 24.70
- M16I (p.Met16Ile), NCI-TCGA Cosmic COSV5923, cosmic curated COSV59235, REVEL 0.34, CADD 22.20, Variant assessed as somatic; moderate impact.
- K17E (p.Lys17Glu), rs750397219, ClinGen CA5929146, ClinVar RCV003008479, ExAC rs750397219, REVEL 0.18, CADD 23.00, Uncertain significance, not provided
- K17M (p.Lys17Met), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K17N (p.Lys17Asn), NCI-TCGA Cosmic COSV5923, cosmic curated COSV59238, MetaLR 0.19, MetaSVM -0.80, Variant assessed as somatic; moderate impact.
- K17K (p.Lys17Lys), gnomAD 11-27658514-C-T, CADD 10.60
- A18P (p.Ala18Pro), gnomAD 11-27658513-C-G, REVEL 0.51, MetaLR 0.46
- A18A (p.Ala18Ala), gnomAD 11-27674273-G-T, CADD 5.59
- A18G (p.Ala18Gly), rs767394378, gnomAD 11-27674274-G-C, CADD 15.40, SIFT 0.02
- A18D (p.Ala18Asp), gnomAD 11-27674274-G-T, CADD 15.70, SIFT 0.00
- A18S (p.Ala18Ser), gnomAD 11-27674275-C-A, CADD 3.47, SIFT 0.02
- A18T (p.Ala18Thr), rs1312832856, gnomAD 11-27674275-C-T, CADD 0.06, SIFT 0.53
- A19E (p.Ala19Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- A19V (p.Ala19Val), NCI-TCGA TCGA novel, TOPMed rs1852864621, REVEL 0.48, CADD 27.90, Variant assessed as somatic; moderate impact.
- P20S (p.Pro20Ser), Ensembl rs868827437, MetaLR 0.26, MetaSVM -0.65
- P20L (p.Pro20Leu), gnomAD 11-27658506-G-A, REVEL 0.57, MetaLR 0.26
- M21I (p.Met21Ile), cosmic curated COSV59238, REVEL 0.29, CADD 21.90
- K22N (p.Lys22Asn), gnomAD 11-27658499-T-A, REVEL 0.22, MetaLR 0.35
- K22K (p.Lys22Lys), rs1381981819, gnomAD 11-27674204-T-C, CADD 3.73
- K22E (p.Lys22Glu), gnomAD 11-27674206-T-C, CADD 19.60, SIFT 0.01
- K22Q (p.Lys22Gln), rs1564961173, gnomAD 11-27674206-T-G, CADD 19.10, SIFT 0.29
- E23D (p.Glu23Asp), gnomAD rs1466411756, REVEL 0.23, CADD 18.30
- E23K (p.Glu23Lys), cosmic curated COSV10883, Ensembl rs2133784956, CADD 19.30, Benign, Obesity
- E23A (p.Glu23Ala), gnomAD 11-27658497-T-G, REVEL 0.32, MetaLR 0.38
- E23E (p.Glu23Glu), rs1342770334, gnomAD 11-27674216-C-T, CADD 5.32
- E23G (p.Glu23Gly), gnomAD 11-27674217-T-C, CADD 20.30, SIFT 0.00
- E23* (p.Glu23Ter), gnomAD 11-27674218-C-A, CADD 33.00
- E23Q (p.Glu23Gln), gnomAD 11-27674257-C-G, CADD 8.25, SIFT 0.02
- A24T (p.Ala24Thr), rs764254110, ClinGen CA5929145, ClinVar RCV002836785, ExAC rs764254110, REVEL 0.12, CADD 18.60, Uncertain significance, Inborn genetic diseases
- A24S (p.Ala24Ser), gnomAD 11-27658495-C-A, REVEL 0.09, MetaLR 0.17
- A24A (p.Ala24Ala), rs769115694, gnomAD 11-27674219-A-G, CADD 6.80
- A24V (p.Ala24Val), rs1206959185, gnomAD 11-27674220-G-A, CADD 5.07, SIFT 0.72
- A24P (p.Ala24Pro), gnomAD 11-27674221-C-G, CADD 2.08, SIFT 0.12
- N25N (p.Asn25Asn), rs760902255, gnomAD 11-27658490-G-A, CADD 4.29
- N25D (p.Asn25Asp), gnomAD 11-27658492-T-C, REVEL 0.12, MetaLR 0.15
- I26I (p.Ile26Ile), rs1482939898, gnomAD 11-27658487-G-T, CADD 8.25
- I26F (p.Ile26Phe), gnomAD 11-27658489-T-A, REVEL 0.04, MetaLR 0.08
- I26V (p.Ile26Val), gnomAD 11-27658489-T-C, REVEL 0.03, MetaLR 0.04
- R27* (p.Arg27Ter), rs267602837, Ensembl rs267602837, Variant assessed as somatic; high impact.
- R27Q (p.Arg27Gln), TOPMed rs990506363, gnomAD rs990506363, REVEL 0.04, CADD 19.90
- R27P (p.Arg27Pro), gnomAD 11-27658485-C-G, REVEL 0.18, MetaLR 0.23
- R27K (p.Arg27Lys), rs982182462, gnomAD 11-27658569-C-T, MetaLR 0.40, MetaSVM -0.26
- R27S (p.Arg27Ser), rs964637486, gnomAD 11-27674246-C-A, CADD 20.20, SIFT 0.00
- R27R (p.Arg27Arg), rs964637486, gnomAD 11-27674246-C-T, CADD 8.19
- R27M (p.Arg27Met), gnomAD 11-27674247-C-A, CADD 23.40, SIFT 0.00
- p.Gly28 Gln29insHisArgGly, gnomAD 11-27658478-T-TTG, CADD 15.60
- G28A (p.Gly28Ala), rs747423302, gnomAD 11-27674202-C-G, CADD 10.70, SIFT 0.00
- G28E (p.Gly28Glu), gnomAD 11-27674202-C-T, CADD 12.10, SIFT 0.00
- G28V (p.Gly28Val), gnomAD 11-27674202-C-A, CADD 13.00, SIFT 0.00
- G28R (p.Gly28Arg), gnomAD 11-27674203-C-T, CADD 19.00, SIFT 0.00
- Q29H (p.Gln29His), NCI-TCGA Cosmic COSV5923, cosmic curated COSV59233, Variant assessed as somatic; moderate impact.
- Q29R (p.Gln29Arg), TOPMed rs1852859318
- Q29Q (p.Gln29Gln), gnomAD 11-27658478-T-C, CADD 9.36
- Q29K (p.Gln29Lys), gnomAD 11-27658579-G-T, MetaLR 0.39, MetaSVM -0.26
- Q29E (p.Gln29Glu), gnomAD 11-27658579-G-C, MetaLR 0.40, MetaSVM -0.27
- Q29* (p.Gln29Ter), gnomAD 11-27674137-G-A, CADD 33.00
- Q29L (p.Gln29Leu), gnomAD 11-27674196-T-A, CADD 9.81, SIFT 0.01
- G30D (p.Gly30Asp), gnomAD 11-27658476-C-T, REVEL 0.36, MetaLR 0.37
- G30R (p.Gly30Arg), gnomAD 11-27658477-C-G, REVEL 0.24, MetaLR 0.24
- G31D (p.Gly31Asp), rs767681787, ClinGen CA5929143, ClinVar RCV003408713, ExAC rs767681787, REVEL 0.06, CADD 19.90, Uncertain significance, BDNF-related disorder
- G31V (p.Gly31Val), ExAC rs767681787, TOPMed rs767681787, gnomAD rs767681787, REVEL 0.11, CADD 22.60, Uncertain significance
- L32W (p.Leu32Trp), gnomAD 11-27658470-A-C, REVEL 0.36, MetaLR 0.43
- L32V (p.Leu32Val), gnomAD 11-27658471-A-C, REVEL 0.18, MetaLR 0.17
- L32F (p.Leu32Phe), gnomAD 11-27674198-C-A, CADD 15.40, SIFT 0.00
- L32L (p.Leu32Leu), gnomAD 11-27674198-C-T, CADD 4.61
- L32M (p.Leu32Met), gnomAD 11-27674200-A-T, CADD 16.40, SIFT 0.00
- L32I (p.Leu32Ile), gnomAD 11-27674212-G-T, CADD 23.30, SIFT 0.32
- A33V (p.Ala33Val), NCI-TCGA TCGA novel, gnomAD rs1852858181, REVEL 0.11, CADD 21.90, Variant assessed as somatic; moderate impact.
- A33A (p.Ala33Ala), rs1212691303, gnomAD 11-27658466-G-A, CADD 12.60
- A33L (p.Ala33Leu), rs1359126183, gnomAD 11-27674163-GC-G, CADD 15.50
- A33S (p.Ala33Ser), gnomAD 11-27674164-C-A, CADD 10.50, SIFT 0.25
- A33T (p.Ala33Thr), rs752449726, gnomAD 11-27674164-C-T, CADD 12.50, SIFT 1.00
- Y34F (p.Tyr34Phe), gnomAD 11-27658464-T-A, REVEL 0.23, MetaLR 0.30
- Y34* (p.Tyr34Ter), gnomAD 11-27674114-G-C, CADD 29.90
- Y34H (p.Tyr34His), rs1460649420, gnomAD 11-27674116-A-G, CADD 9.86, SIFT 0.53
- Y34C (p.Tyr34Cys), rs1430258825, gnomAD 11-27674117-C-CAC, CADD 22.10
- Y34Y (p.Tyr34Tyr), rs200573189, gnomAD 11-27674171-G-A, CADD 5.74
- P35Q (p.Pro35Gln), cosmic curated COSV59239
- P35S (p.Pro35Ser), cosmic curated COSV10015, MetaLR 0.46, MetaSVM -0.15
- P35L (p.Pro35Leu), gnomAD 11-27658461-G-A, REVEL 0.32, MetaLR 0.39
- G36A (p.Gly36Ala), TOPMed rs1037807065, gnomAD rs1037807065, MetaLR 0.16, MetaSVM -0.84
- G36D (p.Gly36Asp), TOPMed rs1037807065, gnomAD rs1037807065, REVEL 0.21, CADD 19.40
- G36R (p.Gly36Arg), gnomAD 11-27658459-C-G, REVEL 0.24, MetaLR 0.33
- G36G (p.Gly36Gly), rs144776617, gnomAD 11-27674177-G-A, CADD 5.82
- G36S (p.Gly36Ser), rs1855778350, gnomAD 11-27674179-C-T, CADD 13.40, SIFT 0.01
- V37M (p.Val37Met), ExAC rs759834365, TOPMed rs759834365, gnomAD rs759834365, REVEL 0.04, CADD 17.00
- V37V (p.Val37Val), rs374752426, gnomAD 11-27658454-C-T, CADD 18.20
- V37I (p.Val37Ile), rs756774056, gnomAD 11-27674176-C-T, CADD 1.08, SIFT 0.54
- V37D (p.Val37Asp), gnomAD 11-27674193-A-T, CADD 24.50, SIFT 0.00
- V37A (p.Val37Ala), gnomAD 11-27674193-A-G, CADD 24.00, SIFT 0.00
- R38Q (p.Arg38Gln), rs763357890, ClinGen CA5929138, ClinVar RCV003417144, ExAC rs763357890, REVEL 0.30, CADD 22.90, Uncertain significance, BDNF-related disorder
- R38W (p.Arg38Trp), rs771341699, NCI-TCGA Cosmic COSV5923, cosmic curated COSV59233, ExAC rs771341699, REVEL 0.48, CADD 31.00, Variant assessed as somatic; moderate impact.
- R38R (p.Arg38Arg), rs943009748, gnomAD 11-27658451-C-T, CADD 18.30
- T39A (p.Thr39Ala), cosmic curated COSV10965
- T39I (p.Thr39Ile), gnomAD 11-27658449-G-A, REVEL 0.28, MetaLR 0.40
- T39T (p.Thr39Thr), rs758930198, gnomAD 11-27674186-T-C, CADD 7.73
- T39R (p.Thr39Arg), gnomAD 11-27674187-G-C, CADD 24.00, SIFT 0.02
- H40Y (p.His40Tyr), Ensembl rs1852854398, REVEL 0.33, CADD 25.70
- H40H (p.His40His), gnomAD 11-27658580-G-A, CADD 8.61
- H40Q (p.His40Gln), rs780865517, gnomAD 11-27658580-G-T, MetaLR 0.13, MetaSVM -0.92
- H40R (p.His40Arg), rs1243802728, gnomAD 11-27658581-T-C, MetaLR 0.19, MetaSVM -0.70
- H40N (p.His40Asn), gnomAD 11-27674191-G-T, CADD 22.10, SIFT 0.02
- H40D (p.His40Asp), gnomAD 11-27674260-G-C, CADD 14.70, SIFT 0.05
- G41E (p.Gly41Glu), NCI-TCGA Cosmic COSV1001, cosmic curated COSV10015, Variant assessed as somatic; moderate impact.
- G41R (p.Gly41Arg), ExAC rs773773442, gnomAD rs773773442, NCI-TCGA Cosmic COSV1001, cosmic curated COSV10015, REVEL 0.40, CADD 24.20, Variant assessed as somatic; moderate impact.
- T42I (p.Thr42Ile), cosmic curated COSV10015, MetaLR 0.33, MetaSVM -0.47
- T42T (p.Thr42Thr), gnomAD 11-27658439-A-C, CADD 18.70
- L43P (p.Leu43Pro), rs2538964679, ClinGen CA380074755, ClinVar RCV002839678, REVEL 0.22, CADD 23.10, Uncertain significance, Inborn genetic diseases
- L43L (p.Leu43Leu), gnomAD 11-27658436-C-T, CADD 18.70
- E44K (p.Glu44Lys), cosmic curated COSV59236, TOPMed rs1852853121, gnomAD rs1852853121, REVEL 0.19, CADD 22.80
- E44Q (p.Glu44Gln), gnomAD 11-27658435-C-G, REVEL 0.21, MetaLR 0.29
- S45R (p.Ser45Arg), ExAC rs769259549, gnomAD rs769259549, REVEL 0.18, CADD 24.20
- S45S (p.Ser45Ser), rs747701929, gnomAD 11-27658430-G-A, CADD 17.20
- S45T (p.Ser45Thr), gnomAD 11-27658431-C-G, REVEL 0.19, MetaLR 0.19
- S45G (p.Ser45Gly), gnomAD 11-27658432-T-C, REVEL 0.11, MetaLR 0.18
- V46M (p.Val46Met), rs146354977, ClinGen CA5929134, ClinVar RCV003393061, ClinVar RCV003778321, REVEL 0.08, CADD 14.40, Uncertain significance, BDNF-related disorder; not provided
- V46V (p.Val46Val), gnomAD 11-27658427-C-T, CADD 18.60
- V46I (p.Val46Ile), rs1227278311, gnomAD 11-27674158-C-T, CADD 0.71, SIFT 0.24
- G48R (p.Gly48Arg), TOPMed rs1852851466, gnomAD rs1852851466, REVEL 0.35, CADD 24.70
Public BDNF analysis runs
- BDNF analysis run — BDNF (562 variants) — completed 2026-08-19